A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

Required: CDH17 any tested (testing required; no eligibility threshold specified)

Cannot have received: CDH17-targeting anti-tumor therapy

Received CDH17-targeting anti-tumor therapy

Cannot have received: other investigational product

received other investigational product ... within 4 weeks prior to the first dose

Cannot have received: systemic corticosteroids

received ... systemic corticosteroids ... within 4 weeks prior to the first dose

Cannot have received: major organ surgery

surgery for major organs within 4 weeks prior to the first dose

Cannot have received: anti-tumor therapy

received anti-tumor therapy within 3 weeks or within 5 half-lives prior to the first dose, whichever is shorter

Cannot have received: radiotherapy

received radiotherapy within 2 weeks prior to the first dose